Inari Medical Inc
NASDAQ:NARI
Inari Medical Inc
NASDAQ:NARI
Price:
79.97
USD
Market Closed
Market Cap:
$4.7B
Relative Value
There is not enough data to reliably calculate the relative value of NARI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NARI
Relative Value
Base Case
Not Available
Multiples Across Competitors
NARI Competitors Multiples
Inari Medical Inc Competitors
Inari Medical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Inari Medical Inc
NASDAQ:NARI
|
4.7B USD | 8.1 | -59.5 | -136.7 | -95.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.5B USD | 4.3 | 28.9 | 16.5 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.8B USD | 16.9 | 59.4 | 45 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.9B USD | 5.3 | 40.7 | 20.8 | 25.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.3B USD | 3.2 | 24.3 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 5.3 | 36.5 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43B EUR | 1.8 | 20.3 | 11.3 | 16 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.6B USD | 7.9 | 44.7 | 24.6 | 26.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.4B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.9B USD | 2.1 | 25.6 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.7B USD | 6.1 | 22.3 | 15.7 | 17.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
